Item 2.02 Results of Operations and Financial ConditionOn March 17, 2023, Pear Therapeutics, Inc. (the “Company”) withdrew its revenue and operating guidance for fiscal 2022 and 2023. The Company does not plan to hold a fourth quarter and full year 2022 earnings conference call and webcast.Item 7.01. Regulation FD DisclosureOn March 17, 2023, the Company issued a press release announcing that it is engaged in a process to explore strategic alternatives to maximize shareholder value. A copy of the Company’s press release is included in this Report as Exhibit 99.1 and is incorporated herein by reference.The information in this Current Report, including Exhibit 99.1 attached hereto, is intended(…)
The Latest Press Releases